EuroIntervention PCRonline - Connecting with the community

Just accepted article

Impact of lesion calcification on angiographic outcomes after Absorb everolimus-eluting bioresorbable vascular scaffold implantation: an observation from the ABSORB Japan trial

Disclaimer:

As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers. To read the full content of this article, please download the PDF.

Sign in to download the full article

1. Kurashiki Central Hospital, Kurashiki, Japan; 2. Kurashiki Central Hospital, Kurashiki, Japan; 3. Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands; 4. Teikyo University Hospital, Tokyo, Japan; 5. Mitsui Memorial Hospital, Tokyo, Japan; 6. Kansai Rosai Hospital Cardiovascular Center, Hyogo, Japan; 7. Shinkoga Hospital, Fukuoka, Japan; 8. Iwate Medical University Hospital, Iwate, Japan; 9. Sakakibara Heart Institute, Tokyo, Japan; 10. Saiseikai Kumamoto Hospital, Kumamoto, Japan; 11. Osaka University Hospital, Osaka, Japan; 12. Tokushima Red Cross Hospital, Tokushima, Japan; 13. Miyazaki Medical Association Hospital, Miyazaki, Japan; 14. Abbott Vascular, Santa Clara, CA, USA; 15. Abbott Vascular, Santa Clara, CA, USA; 16. Columbia University Medical Center, NewYork-Presbyterian Hospital, and the Cardiovascular Research Foundation, New York, NY, USA; 17. Beth Israel Deaconess Medical Center, Boston, MA, USA; 18. Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands; 19. Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands; 20. JAPAN

Abstract

Aims: We investigated the impact of lesion calcification on angiographic outcomes after Absorb everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in comparison with those after cobalt chromium everolimus-eluting stent (CoCr-EES) implantation.

Methods and results: The present post-ho…

– OR –